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Joint patient sub-profile-risk modelingBackground and objective: Risk stratification aims to provide physicians with the accurate assessment of a
patient’s clinical risk such that an individualized prevention or management strategy can be developed
and delivered. Existing risk stratification techniques mainly focus on predicting the overall risk of an
individual patient in a supervised manner, and, at the cohort level, often offer little insight beyond a flat
score-based segmentation from the labeled clinical dataset. To this end, in this paper, we propose a new
approach for risk stratification by exploring a large volume of electronic health records (EHRs) in an
unsupervised fashion.
Methods: Along this line, this paper proposes a novel probabilistic topic modeling framework called
probabilistic risk stratification model (PRSM) based on Latent Dirichlet Allocation (LDA). The proposed
PRSM recognizes a patient clinical state as a probabilistic combination of latent sub-profiles, and
generates sub-profile-specific risk tiers of patients from their EHRs in a fully unsupervised fashion. The
achieved stratification results can be easily recognized as high-, medium- and low-risk, respectively. In
addition, we present an extension of PRSM, called weakly supervised PRSM (WS-PRSM) by incorporating
minimum prior information into the model, in order to improve the risk stratification accuracy, and to
make our models highly portable to risk stratification tasks of various diseases.
Results: We verify the effectiveness of the proposed approach on a clinical dataset containing 3463
coronary heart disease (CHD) patient instances. Both PRSM and WS-PRSM were compared with two
established supervised risk stratification algorithms, i.e., logistic regression and support vector machine,
and showed the effectiveness of our models in risk stratification of CHD in terms of the Area Under the
receiver operating characteristic Curve (AUC) analysis. As well, in comparison with PRSM, WS-PRSM has
over 2% performance gain, on the experimental dataset, demonstrating that incorporating risk scoring
knowledge as prior information can improve the performance in risk stratification.
Conclusions: Experimental results reveal that our models achieve competitive performance in risk
stratification in comparison with existing supervised approaches. In addition, the unsupervised nature
of our models makes them highly portable to the risk stratification tasks of various diseases.
Moreover, patient sub-profiles and sub-profile-specific risk tiers generated by our models are coherent
and informative, and provide significant potential to be explored for the further tasks, such as patient
cohort analysis. We hypothesize that the proposed framework can readily meet the demand for risk strat-
ification from a large volume of EHRs in an open-ended fashion.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Risk stratification, as the starting point for developing preven-
tion or management strategies, plays a key role in personalized
medicine, care plan management, drug development, and cost esti-
mation [1,2,19,30]. For health professionals, once they estimate therisk of a patient, they may be able to apply measures to decrease
the risk for the patient and improve the outcome.
Traditional risk stratification models are established on a small
hand-picked subset of patient features (also called risk factors)
from highly stratified patient cohorts [3,4,13,23] such that statisti-
cal analysis techniques (e.g., logistic regression, Cox regression,
etc.) can be employed to train a risk stratification model in which
the contribution of each individual patient feature to the overall
risk of patients can be estimated [7]. The trained model is then
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on which, patient cohorts can be stratified into several tiers, e.g.,
low-, medium-, and high-risk [3,10]. These models are valuable
and have been widely studied in clinical settings, however, they
are fragmented where the conclusion only holds under well-
controlled conditions [13].
Recently, with the rapid development of healthcare information
systems, a large collection of electronic health records (EHRs) has
become available, which provides the opportunity to study medi-
cal cases, evidence and knowledge for various medical applications
[5,24]. In particular, heterogeneous clinical information for
patients (e.g., the patient demographics, laboratory tests results,
radiological examination reports, etc.) are recorded in EHRs, which
suggests data-centric and hypothesis-free approach from which
machine learning techniques can be utilized for risk stratification
[13]. Considerable work has been done in this line in order to
achieve automatic feature selection from a large volume of EHRs,
and significantly improve the accuracy of risk stratification
[6,13,21,23].
However, most of the existing approaches rely on supervised
learning models trained from labeled datasets where each patient’s
EHR instance has been labeled as high-, medium-, or low-risk prior
to training. Such labeled datasets are not always easily obtained
from EHRs in clinical applications [21]. Note that patient risk
scores are seldom explicitly recorded in EHRs. And it is a very
tedious and time-consuming process to label patient dataset, piece
by piece, in a posteriori manner. It has thus motivated the problem
of using unsupervised or weakly supervised approaches for risk
stratification. Another common deficiency of the aforementioned
work is that it only focuses on detecting the overall risk score of
a patient, without performing an in-depth analysis to discover
latent patient sub-profiles and associated risk tiers. In clinical prac-
tice, a patient clinical status may be very complex and dynamic,
such as comorbidities, complications, infections, or poisonings.
This in turn leads to a patient’s EHR to be represented by a mixture
of latent patient sub-profiles, and each sub-profile is described as a
set of patient features with their values [5,25]. Although detecting
patient sub-profiles is a useful step for retrieving more detailed
medical information, the lack of risk analysis on the extracted
patient sub-profiles often limits the effectiveness of the mining
results, as the physicians are not only interested in the overall risk
score of a patient, but also his/her clinical characteristics (i.e., sub-
profiles) and the risk toward the specific sub-profiles discovered.
For example, coronary heart disease (CHD) patients with high-
risks may have different sub-profiles, e.g., CHD with diabetes, or
CHD with renal insufficiency, etc. Note that different clinical sub-
profiles may result in different treatment plans for patients. In this
sense, detecting a patient’s clinical sub-profiles and stratifying his/
her risk in an integrated manner can provide meaningful values to
the physicians with more informative risk scoring of the patient.
In this paper, we propose a novel probabilistic topic model, i.e.,
probabilistic risk stratification model (PRSM), which integrates
patient sub-profile discovery and risk stratification from EHRs in
an unsupervised manner. The proposed PRSM is an extension of
the state-of-the-art topic model Latent Dirichlet Allocation (LDA)
[26], by constructing an additional risk tier layer, assuming that
risk tiers are generated dependent on patient sub-profile distribu-
tion, and patient features are generated dependent on the joint risk
tier-patient sub-profile distributions. In this way, our model links
both patient sub-profile discovery and risk stratification simulta-
neously. In addition, we incorporate prior knowledge into the
PRSM, called weakly supervised PRSM (WS-PRSM), to improve its
accuracy, and more importantly, makes it highly portable to risk
stratification tasks of various diseases. To the best of our knowl-
edge, no other existing approaches present the same merits as
our models.The proposed approach is evaluated on a collection containing
3463 EHRs of CHD patients collected from the Cardiology Depart-
ment of the Chinese PLA General Hospital. Experimental results
validate the feasibility of jointly modeling risk tiers and patient
sub-profiles from EHR data, and show that our models achieve
comparable performance compared to existing supervised algo-
rithms. Aside from automatically stratify patient risks using EHR
data, our model can also extract meaningful patient sub-profiles
with risk associations as illustrated by some patient sub-profile
examples extracted from the experimental dataset.
The rest of this article is structured as follows. Section 2 sum-
marizes some related studies. Section 3 presents preliminary
knowledge of the proposed approach. Section 4 describes the pro-
posed approach for risk stratification associated with the discovery
of latent patient sub-profiles from EHRs. Section 5 carefully pre-
sents our experimental results on a clinical dataset collected from
a Chinese hospital. Finally, some conclusions are given in Section 6.2. Related work
As a fundamental problem for medical informatics, risk stratifi-
cation is indispensable to modern clinical decision support systems
by providing healthcare practitioners an assessment of an individ-
ual’s risk against an adverse outcome [6,9]. Great bulk of work has
been focused on the problem of risk stratification. Taking coronary
heart disease (CHD) as an example, recent systematic reviews
found that there are over 100 CHD risk stratification models pro-
duced between 1999 and 2009 [17,18], and the vast majority of
these models are based on statistical analysis techniques [7,15].
For example, Fonarow et al., developed a classification and regres-
sion tree for risk stratification of patients hospitalized with the
Acute Decompensated Heart Failure (ADHF). Their experimental
results revealed that ADHF patients at low-, medium-, and high-
risk for in-hospital mortality can be easily identified using vital
sign and laboratory data obtained on hospital admission [22].
Wang et al., extended the linear regression model for risk stratifi-
cation that provides clinicians with not only the accurate assess-
ment of a patient’s risk but also the clinical context to be acted
upon [7]. It must mention that nearly all studies along this line
have been estimated using a small hand-picked subset of features
from highly stratified patient cohorts. As a result, they merely
account for a small number of predetermined risk factors and are
fragmented where the conclusion only holds under well-
controlled conditions [13].
With the widely adoption of electronic health record (EHR) in
healthcare organizations, more advanced machine learning and
data mining algorithms were introduced into risk stratification
[6,13,19,20]. EHR typically contains a diverse set of information
types, including patient demographics, symptoms, vital signs, lab-
oratory tests and treatments, etc., which provides a comprehensive
source for risk stratification. Many machines learning techniques,
such as decision trees [12], Bayesian network [13], and fuzzy infer-
ence system [16], have been proposed to explore the huge poten-
tials of EHR data for risk stratification applications. For example,
Karaolis et al., carried out data mining analysis using the C4.5 deci-
sion tree algorithm to assess the risk factors of coronary heart
events [12]. Bandyopadhyay et al., presented a machine learning
approach based on Bayesian networks trained on EHR data to pre-
dict the probability of cardiovascular events [13]. Liu et al., present
an intelligent scoring system for risk stratification of chest pain
patients. In particular, they adopted a hybrid sampling-based
ensemble learning strategy to handle EHR data imbalance problem
[11]. Singh et al., evaluated three different approaches that use
machine learning to build predictive models using temporal EHR
data of patients with compromised kidney function. Their
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tion in patient’s medical history can lead to better prediction of
loss of kidney function [23]. Tran et al., constructed an ordinal
regression framework for predicting suicide risks from EHR data.
They demonstrate that their methods outperform clinicians to a
large margin, discover suicide risk factors that conform to mental
health knowledge, and produce models with enhanced stability
[14]. In our previous work, we developed a genetic fuzzy system
for unstable angina risk prediction. The system is evaluated using
a real data-set collected from the hospital information system of
a Chinese hospital [16].
However, as can be easily pointed out, all the aforementioned
work shares some similar limitations: (1) they focused on risk
stratification alone without considering the mixture of patient
sub-profiles hidden in EHRs, which limits the effectiveness of the
mining results to users; and (2) most existing approaches are
favored in supervised learning, which require a labeled dataset
for training and potentially restrain their applicability to clinical
settings where the target value (risk) is too difficult to query of.
Motivated by these observations, this study proposes a novel prob-
abilistic topic model, which distinguishes from other models in
that: (1) our model is fully unsupervised; and (2) our model can
provide risk stratification and detect latent patient sub-profiles
simultaneously. This feature provides significant potential to be
explored for the further tasks, including patient cohort analysis.
To the best of our knowledge, no other existing approaches present
the same merits as our model.3. Preliminaries
Here, we introduce our notations and terminologies for the pro-
posed approach. Formally, let D ¼ fd1; . . . ; djDjg be a collection of
EHRs, F ¼ ff 1; . . . ; f jFjg represent all observable patient features
that appear in D, including patient demographics, lab tests results,
vital signs, etc., and R ¼ fr1; . . . ; rjRjg be a set of risk tiers, such as
‘‘low-risk”, ‘‘medium-risk”, and ‘‘high-risk”. Each patient feature f
has an underlying value domain1, denoted as domðf Þ. Each EHR d
(d 2 D), corresponding to a particular patient, contains a set of
patient feature-value pairs to describe the patient clinical status on
a particular time instant of risk stratification, i.e.,
d ¼ fhf 1; v1i; . . . ; hf n;vnig, where f 1; . . . ; f n 2 F, and v i (v i 2 domðf iÞ)
is the target value of feature f i for EHR d.
For example, Table 1 shows an example collection of EHRs,
which consists of three patient instances. Each instance contains
7 patient features (i.e., age, gender, smoking status, angina, diabetes,
hypertension, and total cholesterol). Note that a patient’s EHR may
miss the values of some features because these values are not
always available.
In clinical practice, a patient’s EHR, describing a specific patient
profile at a particular time instant, is a mixture of multiple patient
sub-profiles Z. A patient sub-profile z (z 2 Z) is a latent and abstract
variable represented as a multinomial distribution over a set of
patient feature-value pairs fhf ;vijv 2 domðf Þg. Note that even for
patients with the same first diagnosis, they may have different
sub-profiles due to the differences of their individual symptoms,
vital signs, family disease history and individual disease history,
etc. From a collection of EHRs, an unsupervised approach can auto-
matically discover the highly related patient feature-value pairs
that compose a specific sub-profile by taking advantage of their
co-occurrences. Once a group of highly related patient feature-1 In clinical practice, a patient feature may have a categorical or numerical
underlying domain. In this study, we simply divide the value domain of a numerical
patient feature into a series of categories by referring specific clinical guidelines and
protocols of CHD.value pairs is derived from data, users can assign them meaningful
tags for binding them with further clinical applications, such as
risk stratification illustrated in this study.
4. Method
Realizing the needs above for the risk stratification in an unsu-
pervised manner, in this section, we first propose a probabilistic
topic modeling framework for the task of risk stratification from
EHRs. Then we incorporate prior information into the proposed
model to improve the accuracy of risk stratification.
4.1. Risk stratification model
The Latent Dirichlet Allocation (LDA) model, as shown in Fig. 1
(A), is one of the most popular probabilistic topic models based on
the assumption that documents are a mixture of topics, where a
topic is a probability distribution over words [26]. Shifting to the
clinical setting, we can extend the LDA model to generate patient
instances in a probabilistic procedure [28]. In particular, we pro-
pose an LDA-based topic model called probabilistic risk stratifica-
tion model (PRSM). As shown in Fig. 1(B), PRSM is effectively a
four-layer graphical model, where risk tiers are associated with
EHRs, under which patient sub-profiles are associated with risk
tiers, and patient feature-value pairs are associated with both risk
tiers and clinical sub-profiles.
To stratify patient risks, the proposed PRSM should figure out
patient sub-profiles that are influenced by feature-value pairs con-
tained in EHRs. The generative process for measured patient
feature-value pairs is similar as that of standard topic models.
Assume that we have a collection of D EHRs, each record d corre-
sponds to a particular patient trace, and consists of a set of Nd
patient feature-value pairs fhf ;vig. Each hf ;vi in d is a pair of
patient feature and value, where f 2 F, and v 2 domðf Þ. The proce-
dure for generating a patient feature-value pair hf ;vi of an EHR d
under PRSM boils down to four stages. First, one chooses a patient
sub-profile z from the sub-profile proportions hd that are sampled
from a Dirichlet distribution with prior a. Following that, one
chooses a risk tier from the risk proportions pd;z, where pd;z is con-
ditioned on the sampled patient sub-profile z and is sampled from
a Dirichlet distribution with prior e. Note that, in PRSM each EHR is
associated with Z risk distributions, each of which corresponds to a
patient sub-profile z with the same number of risk tiers. This fea-
ture essentially provides meanings for the proposed PRSM to pre-
dict the risk tier associated with extracted sub-profiles of a patient.
Thirdly, for each of the Nd patient feature-value pairs, both a
patient sub-profile z and a risk tier r are chosen from patient
sub-profile proportions and risk tier proportions, respectively such
that patient feature f is sampled from a joint aspect-risk multino-
mial distribution /z;r which follows a Dirichlet distribution with a
prior b. Finally, the value of patient feature f is generated from the
multinomial distribution wz;r;f . There are, in total, Z  R F prior
distributions of patient feature-value pairs, which follow a Dirich-
let distribution with prior c.
In summary, the proposed PRSM assumes the following gener-
ative process for the collection of EHRs D:
1. For each patient sub-profile z 2 f1; . . . ; Zg, and each risk tier
r 2 f1; . . . ;Rg
(a) For each patient feature, draw /z;r  Dirðbz;rÞ.
(b) For each value in the value domain of patient feature f , draw
wz;r;f  Dirðcz;r;f Þ.
2. For each EHR d, choose a distribution hd  DirðaÞ.
3. For each risk tier r under d, choose a distribution pd;z  DirðeÞ.
4. For each patient feature-value pair hf i;v ii in d
Table 1
An example collection of EHRs.
Age Gender Smoking status Angina Diabetes Hypertension Total cholesterol
d1 Old Male Y Y Y Y H
d2 Middle-age Male Y Y Y H
d3 Old Female N Y Y Y N
Fig. 1. (A) LDA model, (B) probabilistic risk stratification model, and (C) weakly supervised probabilistic risk stratification model. The graphical models represent
dependencies among variables. The shaded and unshaded nodes indicate observed and latent variables respectively. The plate indicates replicates, and the value in the plate
indicates replicates, and the value in the plate indicates the number of replicates.
Z. Huang et al. / Journal of Biomedical Informatics 58 (2015) 28–36 31(a) Choose a patient sub-profile zi  MultðhdÞ.
(b) Choose a risk tier ri  Multðpd;zi Þ.
(c) Choose a patient feature f i  Multð/zi ;ri Þ.
(d) Choose a value v i  Multðuzi ;ri ;f i Þ.
Note that hyper-parameters a, e, b, and c in PRSM can be treated
as the prior observation counts for the number of times patient
sub-profile z sampled from a patient’s EHR, the number of times
risk tier r associated with sub-profile z is sampled from an EHR,
the number of times patient feature f sampled from sub-profile z
is associated with risk tier r, and the number of times the values
v of patient feature f from sub-profile z is associated with risk tier
r, respectively, before any patient feature-value pair from the EHR
collection is observed. In this study, we used asymmetric prior e
and symmetric priors a, b, and c.
In addition, there are four sets of latent variables that we need
to infer in PRSM, i.e., the per-EHR patient sub-profile distribution h,
the per-EHR patient sub-profile-specific risk tier distribution p, the
joint sub-profile-risk tier-feature distribution /, and the joint sub-
profile-risk tier-feature-value distribution w. To obtain the distri-
bution of h, p, /, and w, we first estimate the posterior distribution
over z, and r, i.e., the assignment of feature-value pairs to both
patient sub-profiles and risk tiers. The sampling distribution for a
patient feature-value pair given the remaining patient sub-
profiles and risk tiers is Pðzi ¼ z; ri ¼ rjf ;v ; zi; ri;a; b; c; eÞ, where
zi and ri are vectors of assignments of patient sub-profiles andrisk tiers for all patient feature-value pairs in the collection of EHRs
except for the patient feature-value pair at position i of EHR d.
Our interest is in the distribution Pðf ;v ; z; rja; b; c; eÞ. As indi-
cated in [26], exact inference is known to be intractable in the
LDA family, and thus we resort to approximate inference using
Gibbs sampling. This is achieved by integrating out the parameter
random variables, and taking advantages of conjugacy to derive a
close form for the Gibbs conditional distribution
Pðzi; rijzi; ri; f ;v ;a; b; c; eÞ. Because the parameter variables are
integrated out during sampling, this is also known as collapsed
Gibbs sampling. We start the joint distribution in the following
equation:
Pðf ;v ; z; rja;b; c; eÞ ¼ Pðv jf ; z; r; cÞPðf jz; r;bÞPðrjz; eÞPðzjaÞ ð1Þ
For the first term Pðv jf ; z; r; cÞ, by integrating out w, we have:
Pðvjf ; z; r; cÞ /
YZ
z¼1
YR
r¼1
YF
f¼1
Qdomðf Þ
v¼1 CðNz;r;f ;v þ cÞ
CðNz;r;f þ VfcÞ ð2Þ
where Nz;r;f ;v is the number of times the value v of patient feature f
being assigned to sub-profile z and risk tier r, Nz;r;f is the number of
times the patient feature f being assigned to sub-profile z and risk
tier r, and C is the gamma function.
For the second term Pðf jz; r; bÞ, by integrating out /, we have
Pðf jz; r; bÞ /
YZ
z¼1
YR
r¼1
QF
f¼1CðNz;r;f þ bÞ
CðNz;r þ FbÞ ð3Þ
32 Z. Huang et al. / Journal of Biomedical Informatics 58 (2015) 28–36where Nz;r;f is the number of times patient feature f being assigned
to sub-profile z and risk tier r, and Nz;r is the number of times
patient features being assigned to sub-profile z and risk tier r.
For the third term Pðrjz; eÞ, by integrating out p, we have
Pðrjz; eÞ /
YD
d¼1
YZ
z¼1
QR
r¼1CðNd;z;r þ erÞ
CðPr02RNd;z;r0 þPr0er0 Þ ð4Þ
where Nd;z;r is the number of times a patient feature-value pair from
EHR d being assigned to sub-profile z and risk tier r, and Nd;z is the
number of times sub-profile z being assigned to some patient
feature-value pairs in d.
For the fourth term PðzjaÞ, by integrating out h, we have:
PðzjaÞ /
YD
d¼1
Q Z
z¼1CðNd;z þ aÞ
CðNd þ ZaÞ ð5Þ
where Nd;z is the number of times a patient feature-value pair from
EHR d being assigned to sub-profile z, and Nd is the number of
patient feature-value pairs in d.
Our objective is to derive the conditional Gibbs distribution
Pðzi ¼ z; ri ¼ rjf ;v ; zi; ri;a; b; c; dÞ, where zi ¼ z=fzig and
ri ¼ r=frig denote the set of remaining patient sub-profiles and
risk tiers at position i in d. Substituting Eqs. (2)–(5) into Eq. (1),
we obtain the conditional Gibbs distribution as follows:
Pðzi ¼ z; ri ¼ rjf ;v ; zi; ri;a;b; c; eÞ
/ Nz;r;f ;v þ c
Nz;r;f þ jdomðf Þj  c 
Nz;r;f þ b
Nz;r þ jFj  b 
Nd;z;r þ erP
r02RNd;z;r0 þ
P
r02Rer0
 Nd;z þ a
Nd þ Za ð6Þ
Consider Eq. (6), which computes a probability of a certain
patient sub-profile and a certain risk tier for the ith present patient
feature-value pair in d. In particular, the value information of
patient features is inferred from Eq. (6). Suppose that we are cur-
rently determining the probability that patient clinical sub-
profile and risk tier of the present patient feature f are z and r,
Eq. (6) determines the probability of the value of f under z and r.
The pseudocode for the Gibbs sampling procedure of PRSM is
shown in Algorithm 1, where the posterior estimates in Eqs. (7)–
(10) are used to derive patient sub-profiles and risk tiers.
Algorithm 1. Gibbs sampling for PRSM1 Input:
2 An EHR collection D, hyper-parameters a, b, c, and e
3 Steps:
4 Initialize the count parameters Nz;r;f ;v ¼ 0, Nz;r;f ¼ 0,
Nd;z;r ¼ 0, and Nd;z ¼ 0
5 Iterate over each patient feature-value pair hf ;vi in the
EHR collection  
6 Sample a patient sub-profile z  Mult 1Z , and a risk
tier r  Mult 1R
 7 Update the count parameters Nz;r;f ;v ¼ Nz;r;f ;v þ 1,
Nz;r;f ¼ Nz;r;f þ 1, Nd;z;r ¼ Nd;z;r þ 1, and Nd;z ¼ Nd;z þ 18 Iterate over a large number of iterations (e.g. 1000):
9 Iterate over each EHR d in D
10 Iterate over each patient feature-value pair hf ; vi in
d
11 Decrement the sub-profile/risk/feature/value,
sub-profile/risk/feature, record/sub-profile/risk, and
record/sub-profile counts as follows Nz;r;f ;v ¼ Nz;r;f ;v  1,
Nz;r;f ¼ Nz;r;f  1, Nd;z;r ¼ Nd;z;r  1, and Nd;z ¼ Nd;z  112 Sample a patient sub-profile z and a risk tier r
assignment for a patient feature-value pair hf ;vi according
to Eq. (6)13 Increment the new sub-profile/risk/feature/value,
sub-profile/risk/feature, record/sub-profile/risk, and
record/sub-profile counts as follows Nz;r;f ;v ¼ Nz;r;f ;v þ 1,
Nz;r;f ¼ Nz;r;f þ 1, Nd;z;r ¼ Nd;z;r þ 1, and Nd;z ¼ Nd;z þ 114 Output:
15 Estimate the model parameters with sampling results as
follows:w^z;r;f ;v ¼ Nz;r;f ;v þ cNz;r;f þ Vf ic
ð7Þ/^z;r;f ¼ Nz;r;f þ bNz;r þ Fb ð8Þ
p^d;z;r ¼ Nd;z;r þ erP
r02RNd;z;r0 þ
P
r02Rer0
ð9Þ
h^d;z ¼ Nd;z þ aNd þ Za ð10ÞThe complexity of deriving a sample from Eq. (6) is OðZRÞ, making
an overall complexity of OðNZRÞ for each Gibbs round, where Z is
the number of patient sub-profiles in consideration, R is the number
of risk tiers, and N ¼Pd2DNd is the number of patient feature-value
pairs in an EHR collection D. Thus, the total complexity for L Gibbs
samples is OðLNZRÞ. In practice, Z and R are often fixed in advance,
making N the main factor that contributes to the complexity. In
other words, the proposed PRSM scales linearly with the number
of patient feature-value pairs recorded in the data collection.
As we can see, PRSM is now explicitly capturing the associations
between patient feature-value pairs, sub-profiles and risk tiers. By
learning the parameters of the model, we obtain the set of patient
sub-profiles that appear in an EHR collection and their relevance to
different EHRs, which truly models essential patient features and
also possible value instants of these features. Thus, a distribution
over risk tiers for patient instance PðrjdÞ can be calculated based
on the patient sub-profile-risk tier distribution p and the per-
EHR sub-profile proportion h as follows:
PðrjdÞ ¼
X
z2Z
Pðrjz;dÞPðzjdÞ ð11Þ
The risk stratification of EHRs is conducted based on PðrjdÞ, the
probability of a risk tier r given d. In our experiments, we consider
the probability of high-, medium-, and low-risk tiers for a given
patient medical record. Therefore, we define that a patient is strat-
ified as a high-risk tier if the probability of a high-risk tier
Pðrhigh-riskjdÞ is greater than its probability of medium- and low-
risk tiers Pðrmedium-riskjdÞ and Pðrlow-riskjdÞ, and vice versa.
4.2. Weakly supervised probabilistic risk stratification model
As we mentioned above, the proposed PRSM is a fully unsuper-
vised approach to risk stratification. Discovered stratification
results can be easily recognized as high-, medium- and low-risk,
respectively, by clinicians. To improve the accuracy of risk stratifi-
cation, one possible direction is to incorporate prior information
about patient risk stratification of a particular disease. In this
study, we investigate incorporating prior information obtained
from clinical guidelines and protocols into the proposed PRSM,
and proposed a weakly supervised PRSM (WS-PRSM) to explore
how the prior information can improve the patient risk stratifica-
tion accuracy. As shown in Fig. 1(C), we add an additional depen-
dency link of /, and w on the matrix x of size R F  domðFÞ,
0.8
0.82
0.84
0.86
0.88
0.9
0.92
1 2 3 4 5 6 7 8 9 10
AU
C
Number of patient sub-profiles
WS-PRSM PRSM LR SVM
Fig. 2. AUC for the collected dataset.
Z. Huang et al. / Journal of Biomedical Informatics 58 (2015) 28–36 33which we apply to encode prior risk information of particular
patient feature-value pairs into the PRSM. The matrix x can be
considered as a transformation matrix which modifies the Dirichlet
priors b of size Z  R F, and the Dirichlet priors c of size
Z  R F  domðFÞ, such that the prior information of risk
stratification on a particular patient feature-value pair hf ;vi can
be captured.
The complete procedure of incorporating prior information of
risk stratification into the PRSM model is as follows: first, x is
initialized with all the elements taking a value of 1. Then, for each
patient feature-value pair hf ;vi and for each risk score
r 2 f1; . . . ;Rg, if hf ;vi is found in the prior lexicon of risk stratifica-
tion, the element xr;f ;v is updated as follows:
xr;f ;v ¼
1; if Dðf ;vÞ ¼ r
0; otherwise

ð12Þ
where the function Dðf ;vÞ returns the prior risk score of hf ; vi in a
lexicon of risk stratification. For example, the patient feature value
pair (age, very-old) is a high-risk indicator. The corresponding row
vector in x is [0, 0, 1] with its elements representing low-risk,
medium-risk, and high-risk indicator. For each patient sub-profile
z 2 f1; . . . ; Zg, multiplying xr;f ;v with bz;r;f and cz;r;f ;v , only the value
of bz;high-risk;f and cz;high-risk;f ;v are retained, and bz;low-risk;f , bz;medium-risk;f ,
cz;low-risk;f ;v and cz;medium-risk;f ;v are set to 0.
In comparison with PRSM, the proposed WS-PRSM shown in
Fig. 1(C) is weakly supervised with only minimum prior informa-
tion being incorporated, which in turn is more flexible.Table 2
The details of the experimental dataset.
Number
of
patient
traces
Number of feature-
value pairs
Number of
feature types
Minimum
length of
stay (day)
Maximum
length of
stay (day)
Average
length
of
stay
(day)
3463 348,758 257 1 94 8.3
Rank Patient feature-value pair Frequency
1 Swollen tonsils – False 3434
2 Sternum percussion pain – False 3426
3 Varicose veins – False 3377
4 Hepatitis – False 3280
5 Hemorrhage – False 3276
6 Normal heart rhythm – True 3243
7 Family history of CHD – False 3226
8 Sodium – Normal 3148
9 Leg edema – True 3103
10 Creatine kinase – Normal 29925. Experiments
5.1. Data collection
In this case study, a collection of EHRs consisting of 3463 unsta-
ble angina patient instances was extracted from hospital informa-
tion systems of Chinese PLA General Hospital to demonstrate the
feasibility of the proposed approach. As suggested by our clinical
collaborators and to provide risk stratification service in an early
stage of patient treatment processes, we extracted experimental
dataset from admission records of patients, i.e., the patient data
recorded in the admission stage were collected from the EHR sys-
tem. The average length of stay (LOS) of selected patients is 8.30
days, which some patients take a very short time, e.g., only 1 day
in hospital, and others take much longer, e.g., more than 3 months
in the hospital, which implicitly indicates the diversity of patient
conditions in treatment processes. Preprocessing was performed
on the experimental data-set. In particular, numerical patient fea-
tures were normalized. For example, feature values of some lab
tests are categorized into 3 different classes: L (low), N (normal),and H (high), according to the lab test protocols of the hospital.
As a result, the collected data-set have 348,758 patient feature-
value pairs within 257 feature types. Summary statistics of the
dataset are shown in Table 2.
For patient feature-value pairs, we calculate the frequency
curve of patient feature-value pairs as shown in Table 2, which
demonstrates that there are about 348,758 patient feature-value
pairs in the experimental dataset. On the bottom of Table 2, it
shows the top 10 patient feature-value pairs and their frequencies,
which are larger than 3000 (except the last one).
5.2. Experimental setting
For training the proposed PRSM and WS-PRSM, the hyper-
parameter a is set to 50
# sub-profiles, b and c are set to 0.01. It should
be noted that while the standard LDA can produce reasonable
results with a simple uniform Dirichlet prior for its hyper-
parameters, asymmetric prior e for risk tier distribution should
be used since it captures different correlations among risk tiers.
In our experiments, the setting for e was determined empirically
in considering the ratios of patients in the three groups of the
training data set (i.e., 500 labeled EHRs). As results, e is set to 0.1
for high-risk tier, and 1.0 for medium- and low-risk tiers.
In the experiments, a CHD risk lexicon was combined and incor-
porated as prior knowledge into the model learning. The adopted
lexicon contains well recognized risk indicators, e.g., age, gender,
total and high density lipoprotein cholesterol, family history for pre-
mature CHD, smoking status, etc., whose risk tier’s orientation have
been fully specified in the clinical guidelines of CHD [29,12]. The
prior information was produced by retaining all patient feature-
value pairs in the CHD lexicon that occurred in the experimental
data set. Part of the employed CHD lexicon is shown in Table 3.
The case study was performed in the Cardiology Department at
the Chinese PLA General Hospital. Prior approval was obtained
from the data protection committee of the hospital to conduct
the study. We state that the patient data was anonymized in this
study and in this paper. All experiments were performed on a
Lenovo Compatible PC with an Intel Pentium IV CPU 2.8 GHz,
4G byte main memory running on Microsoft Windows 8.1. The
algorithm was implemented using Microsoft C#.
5.3. Risk stratification
As both PRSM and WS-PRSM model risk tiers and patient sub-
profiles simultaneously, it is therefore worth exploring how the
risk stratification and patient sub-profiles extraction tasks benefit
Table 3
Paradigm list of patient feature-value pairs.
High-risk (Age, Very-old), (Age, Old), (Smoking status, Y), (Diabetes, Y),
(Peripheral arterial disease, Y), (Hypertension, Y),
(Hyperlipidemia, Y), (Renal insufficiency, Y), (Family history of
CHD, Y), (History of myocardial infarction, Y), (Post-PCI, Y), (Post-
CABG, Y), (Troponin T, H), (Creatine kinase isoenzyme, H),
(Creatine kinase, H), (Serum creatinine, H), (Total cholesterol, H),
(ST segment depression, Y), (Coronary artery stenosis, >50%)
Medium-
risk
(Age, Old), (Age, Middle-age), (Diabetes, Y), (Peripheral arterial
disease, Y), (Hypertension, Y), (Hyperlipidemia, Y), (Family history
of CHD, Y), (History of myocardial infarction, Y), (Post-PCI, Y),
(Post-CABG, Y), (Troponin T, H), (Creatine kinase isoenzyme, H),
(Creatine kinase, H), (Serum creatinine, H), (Total cholesterol, H),
(ST segment depression, Y)
Low-risk (Age, Young), (Smoking status, N), (Diabetes, N), (Peripheral
arterial disease, N), (Hypertension, N), (Hyperlipidemia, N),
(Family history of CHD, N), (Troponin T, L), (Creatine kinase
isoenzyme, L), (Creatine kinase, L), (Serum creatinine, L), (Total
cholesterol, L), (ST segment depression, N)
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ferent number of patient sub-profiles on the experimental dataset.
Ideally, each patient case in the experimental dataset should be
evaluated by clinicians such that the benchmark patient risk can
be identified by clinicians. However, due to the burden of daily
work of our clinical collaborators, we cannot ask them to validate
all 3463 patient traces for the risk stratification. To validate the
applicability of the proposed method in clinical settings, we ran-
domly selected 500 EHRs as the test data-set, and use the other
EHRs to train the model. W.r.t the ground-truth, we asked three
experienced physicians in the Cardiology Department of the Chi-
nese PLA General Hospital to stratify risks of test patients based
on their EHRs adopting a majority voting. Then, we checked the
consistency of the possible risk tiers suggested by our models with
the ground-truth. In this sense, we investigate the feasibility of
proposed models for risk stratification of CHD patients, as compa-
rable to identify patient risks in comparison with human
evaluation.
In comparison with our models, we employed support vector
machine (SVM) with RBF kernel function and logistic regression
(LR) with ‘1 regularization on the regression coefficients as base-
line approaches. Both approaches have been widely used for risk
stratification and demonstrated good accuracy for CHD risk predic-
tion in the literature [28]. Regarding the benchmark approaches,
we evaluate the stratification performance in terms of AUC using
5-fold cross validation on the 500 labeled EHRs. We first randomly
partitioned the labeled EHR collection into 5 disjoint folds. For each
trial we picked one fold as the test set and a portion of the remain-
ing 4 folds as the training set. As a result, the training-to-test ratio
varied from 1:1 to 4:1. And then, we report the mean AUC over 5-
fold cross validation.
Fig. 2 shows the risk stratification results of both the proposed
models and baseline approaches. Note that we conducted a set of
experiments on the proposed PRSM and WS-PRSM with the num-
ber of patient sub-profiles from 1 to 10. For all the reported results,
the mean Area Under the receiver operating characteristic Curve
(AUC) is used as the performance measure.
As can be seen from Fig. 2, the AUC curves of our models
increase with the increase of the number of patient sub-profiles,
and then remain stable with the further increases of Z. Note that
the proposed models essentially become the standard LDA model
with only three risk tiers when the number of patient sub-
profiles is set to 1, and hence ignore the correlation between
patient sub-profiles and risk tiers. Fig. 2 shows that both PRSM
and WS-PRSM perform better with multiple patient sub-profiles
settings. This observation shows that modeling risk tiers andpatient sub-profiles simultaneously does indeed help improve
the performance of risk stratification.
In comparison with baseline approaches, both PRSM and
WS-PRSM outperform the baselines regardless of the number of
patient sub-profiles. For example, as shown in Fig. 2, the proposed
WS-PRSM has over 4.2% and 8.7% performance gain in comparison
with LR and SVM, respectively, on the experimental dataset, when
Z = 3. Since the proposed models are in an unsupervised fashion, it
is quite remarkable that our models can predict patient risks more
accurately than the benchmark approaches. The advantage of our
models against baseline approaches was particularly significant
when the training-test ratio was small, which is a desirable prop-
erty in practice when training samples are scarce. This is because
our model is generative whereas baseline approaches are discrim-
inative. Therefore, our models can coverage much faster to its
asymptotic error [27].
It must mention that the baseline approaches are supervised
and require physicians to label patient cohorts. In contrast, for
the proposed PRSM and WS-PRSM, no human judgment is
required. Both PRSM and WS-PRSM can give comparable perfor-
mance in risk stratification compared to supervised algorithms.
While comparing PRSM and WS-PRSM, it was observed that
WS-PRSM performs slightly better than PRSM regardless of the
number of patient sub-profiles. It indicates that incorporating prior
knowledge into risk stratification can indeed improve the perfor-
mance of risk stratification. In addition, this strategy also improves
the flexibility of our probabilistic topic modeling framework in risk
stratification for various diseases.
Note that there are several data properties that make our
method suitable for CHD risk stratification. At first, the experimen-
tal data, extracted from the admission records of CHD patients, is
structured. Specifically, these admission records are generated by
the structured template designed by the Cardiology Department
of the hospital. In case that the structured template is not provided
and patient records are written in a free-text style, more efforts, e.
g., nature language processing, should be performed to extract
patient features form data for the further task of CHD risk stratifi-
cation. In addition, the provided template for patient data entry
indicates the second data property, i.e. relevant to CHD. Appar-
ently, the collected patient data is relevant to CHD since the struc-
tured template is provided by physicians from the cardiovascular
department, based on their knowledge and experiences. The third
data property is the normalization of the EHR data. In this study,
we simply divide the value domain of a numerical patient feature
into a series of categories by referring specific clinical guidelines
and protocols of CHD. All these data properties make our models
suitable for CHD risk stratification.
5.4. Patient sub-profile extraction
The second goal of the proposed approach is to extract latent
patient sub-profiles from the experimental dataset, and evaluate
the effectiveness of sub-profile-oriented risk scoring. To this end,
we applied the proposed PRSM to extract latent patient sub-
profiles from the experimental dataset. Unlike the LDA model
where a word is drawn from the topic-word distribution [26], in
our PRSM, one draws patient feature-value pairs conditioned on
both patient sub-profiles and risk tiers. Therefore, we analyze the
extracted latent patient sub-profiles under high-, medium-, and
low-risk tier, separately.
The extracted examples of patient sub-profiles are shown in
Table 4, where each sub-profile was drawn from a particular risk
tier. Each example sub-profile is represented by the top 10 patient
feature-value pairs. As can be seen from the table that the
extracted patient sub-profiles are quite informative and coherent.
In terms of risk orientation of the discovered sub-profiles, by
Table 4
Example of latent patient sub-profiles extracted by PRSM under different risk tiers.
Patient sub-profile 1 Patient sub-profile 2 Patient sub-profile 3
ðf ; vÞ Pðf ;v jz; rÞ ðf ;vÞ Pðf ;v jz; rÞ ðf ; vÞ Pðf ; v jz; rÞ
High-risk
Hemoglobin assay-Low 0.1398 Hepatitis-TRUE 0.0630 CR-High 0.0770
Determination of HCT-Low 0.1224 Determination of plasma prothrombin time-High 0.0616 Age-Very old 0.0716
Red blood cell count-Low 0.0779 Determination of plasma prothrombin activity-Low 0.0465 Renal insufficiency-TRUE 0.0565
Determination of red blood cell volume
distribution width in CV-High
0.0722 Hemorrhage-TRUE 0.0428 Prostate-TRUE 0.0520
CR-High 0.0537 Abnormal liver-TRUE 0.0403 Urea-High 0.0519
Urea-High 0.0451 Paroxysmal nocturnal Dyspnea-TRUE 0.0353 Brain natriuretic peptide
precursor-High
05039
Renal insufficiency-TRUE 0.0341 Brain natriuretic peptide precursor-High 0.0290 Smoking-TRUE 0.0413
Mean corpuscular hemoglobin-Low 0.0340 Cerebrovascular disease-TRUE 0.0277 Serum uric acid-High 0.0412
Determination of plasma d-dimer-High 0.0324 Varicose vein-TRUE 0.0214 Serum Cystatin (Cystatin c)
determination of-High
0.0412
Determination of plasma Fibrinogen-High 0.0300 Total bilirubin-High 0.0214 Cardiac function grade I-TRUE 0.0374
Medium-risk
Gender-male 0.0441 Paroxysmal nocturnal Dyspnea-FALSE 0.0510 CTN T-Normal 0.0331
White blood cell count-Normal 0.0378 Lower extremity edema-TRUE 0.0471 Glucose-High 0.0289
Determination of HCT-Normal 0.0327 High blood pressure-TRUE 0.0460 Magnesium-Normal 0.0279
Mean corpuscular hemoglobin
concentration-Normal
0.0322 Angina-TRUE 0.0438 Lipase-Normal 0.0259
Smoking-TRUE 0.0320 Swollen tonsil-FALSE 0.0427 Lactate dehydrogenase-Normal 0.0257
Red blood cell count-Normal 0.0283 Hemorrhage-FALSE 0.0406 Basophil granulocyte-Normal 0.0220
Determination of plasma d-dimer-Normal 0.0282 Varicose vein-FALSE 0.0406 CK-Normal 0.0216
Determination of thrombin time-Normal 0.0278 Hepatitis-FALSE 0.0370 Quantitative determination of
CKMB-Normal
0.0210
Potassium-Normal 0.0249 Alcohol-FALSE 0.0277 Alp-Normal 0.0183
Age-Middle age 0.0244 Dull pain in the chest discomfort-TRUE 0.0255 Determination of mean platelet
volume-Normal
0.0181
Low-risk
Urine ketone test-Negative 0.0493 Artery stenosis-TRUE 0.0458 Creatine kinase-MB-Normal 0.0558
Examination of red blood cells in urine
(microscope)-Negative
0.0453 Swollen tonsil-FALSE 0.0389 Calcium-Normal 0.0487
Determination of pH of urine-Normal 0.0449 Varicose vein-FALSE 0.0379 Glycosylated serum protein-
Normal
0.0461
Urine tube (microscopic examination)-
Negative
0.0449 Sternum pain-FALSE 0.0364 TBA-Normal 0.0426
Ubil test-Negative 0.0417 Coronary angiography-TRUE 0.0353 APO-B-Normal 0.0423
Determination of serum specific antibody-
Normal
0.0415 Dull pain in the chest discomfort-TRUE 0.0330 Hepatitis c antibody-Normal 0.0391
Examination of epithelial cells in urine
(microscope)-Negative
0.0412 Promoting blood circulation and removing blood
stasis with anticoagulation-TRUE
0.0304 TC-Normal 0.0389
Urinary protein qualitative test-Negative 0.0411 Family history of CHD-FALSE 0.0298 APO-A1-Normal 0.0380
Turbidity in urine-clear 0.0410 Vasodilation-TRUE 0.0296 Serum lipoprotein (a)-Normal 0.0368
Urine nitrite test-Negative 0.0395 High blood pressure-TRUE 0.0294 Low density lipoprotein
cholesterol-Normal
0.0282
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most of the risk specific patient sub-profiles indeed bear the corre-
sponding risk factors (i.e., patient feature-value pairs). For exam-
ple, for the three high-risk oriented patient sub-profiles, the first
two sub-profiles are closely related to patients who have typical
comorbidity Renal insufficiency and Hepatitis, respectively, whereas
the third one discloses several well recognized risk factors of CHD,
e.g., smoking, Very old age, high CR, etc. Regarding the medium-risk
patient sub-profiles, the first one describes middle-age male
patients who are smokers, the second one indicates hypertension
is a common comorbidity of patients with medium-risk, and the
third one discloses that patients who have high Glucose may have
medium-risk of CHD; for the low-risk CHD patients, they have
Artery stenosis but with few comorbidities, and their routine urine
test results (patient sub-profile 1) and blood biochemical test
results (patient sub-profile 3) are quite normal. Overall, the above
analysis illustrates the effectiveness of the proposed model in
extracting risk-oriented patient sub-profiles from EHRs.
The idea to not only assess patient risk levels but also extracting
patient sub-profiles associated with specific risk levels has been
embraced by our clinical collaborators. In particular, they are veryinterested in the extracted patient sub-profiles. For example,
regarding to the second patient sub-profile corresponding to the
high risk level, our clinical collaborators think that the first patient
feature ‘‘Hepatitis” might be a risk factor of CHD. To our best
knowledge, this has never been indicated in literatures. Since China
has a large population of Hepatitis, clinicians think that it may
exist correlation between CHD and Hepatitis for Chinese people.
They will investigate this finding in their clinical research.6. Conclusions
In this paper, we present two probabilistic topic models for risk
stratification. The advantage of our models is that they can accu-
rately stratify the risk for individual patients and extract the dis-
tinct patient sub-profiles with different risk groups from EHRs
simultaneously. In contrast to most of the existing approaches in
risk stratification which favor supervised learning, our models sup-
port risk stratification in an unsupervised fashion, thus provide
more flexibilities and can be easier adapted to the risk stratification
applications of various diseases. Experiments have been conducted
36 Z. Huang et al. / Journal of Biomedical Informatics 58 (2015) 28–36to evaluate the performance of our models based on a CHD dataset
collected from a Chinese hospital. The experimental results show
that our models achieve competitive performance in risk stratifica-
tion compared with the results generated by other existing super-
vised approaches. In addition, the latent sub-profiles of patient
cohorts and sub-profile-oriented risk scores achieved by our mod-
els have been evaluated by clinical experts and are indeed coherent
and informative.
It should be mentioned that there exist some limitations for the
current approach. (1) In this study, the number of latent patient
sub-profiles Z are empirically selected in the experiments. Note
that Z has significant impacts on the performance of patient sub-
profile extraction and associated risk stratification. If Z is set to a
very large value, it might generate several patient sub-profiles that
are blurred and redundant with others. To remedy it, we could
automatically infer the number of patient sub-profiles by extend-
ing the proposed probabilistic topic models to a nonparametric
Bayesian model such as hierarchical Dirichlet processes [31]. (2)
In addition, patient sub-profiles are generated using the data col-
lected at the admission stage of LOS in this study. However, the
dynamic nature of a patient profile is often essential to risk strati-
fication and subsequent treatment interventions adopted in clini-
cal treatment processes. Thus, it would be valuable to provide
continuous risk stratification/prediction service during patients’
LOS. Such a service not only stratifies patient clinical risks at run-
time, but also monitors patient treatment processes in a continu-
ous and predictive fashion. We will address these limitations in
our future work.
The issue of meaningful or secondary use of EHRs represents a
promising and interesting research direction in health informatics
[25]. Our study indicates the feasibility of exploring EHRs to sup-
port risk stratification and clinical decision support. There are
many potential applications of our work, such as individualized
care plan delivery based on risk stratification, and clinical outcome
prediction. As for future work, we intend to carry out a large scale
of experiments and evaluate the model performance on a larger
scale of EHRs from various diseases, as a crucial advantage over
traditional techniques for risk stratification.Conflicts of interest
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